Pfizer tests new eczema pill in first human safety trial
NCT ID NCT06686797
Summary
This is an early safety study by Pfizer for a new oral medicine called PF-08049820, intended to treat moderate-to-severe eczema. The study is testing the medicine in healthy adults to check for side effects and see how the body absorbs and processes it. Researchers will give different doses to small groups of volunteers and closely monitor their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.